Obesity and oxidative stress intensify psoriasis through activating IL-17/IL-23 pathway

被引:0
|
作者
Vikasari, Suci Nar [1 ,3 ]
Sukandar, Elin Yulinah [3 ]
Suciati, Tri [2 ]
Adnyana, I. Ketut [2 ]
机构
[1] Inst Teknol Bandung, Sch Pharm, Doctoral Program Pharm, Bandung, Indonesia
[2] Inst Teknol Bandung, Sch Pharm, Bandung, Indonesia
[3] Univ Jenderal Achmad Yani, Fac Pharm, Cimahi, Indonesia
来源
PHYSIOLOGY AND PHARMACOLOGY | 2024年 / 28卷 / 01期
关键词
Psoriasis; Autoimmune; Obese; Oxidative stress; IL-17/IL-23; pathway; PATHOPHYSIOLOGY; PATHOGENESIS; UPDATE;
D O I
10.61186/phypha.28.1.18
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Psoriasis is an autoimmune disease characterized by keratinocyte hyperproliferation and skin thickening. Psoriasis is caused by a complicated interaction between the innate and acquired immune systems. In the skin, this reaction produces abnormal T helper cell (Th1, Th17, and Th23) reactivation. Keratinocyte hyperproliferation is caused by increased cell (TNF-alpha), and interferon-gamma (INF-gamma). Obesity, free fatty acids, microorganisms in the skin and digestive tract, free radicals in the body, and the cardiovascular system are also essential variables in psoriasis. Several variables influence the cytokine activation of the IL17/IL-23 pathway. Obesity, which is marked by changes in lipid profile in psoriasis patients, is linked to increased oxidative stress and the generation of proinflammatory cytokines, both of which can potentially trigger psoriasis relapse. Antioxidant-rich diet and intake can be employed as one of the stages in preventing psoriasis recurrence.
引用
收藏
页码:18 / 26
页数:9
相关论文
共 50 条
  • [1] Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis
    Ghoreschi, Kamran
    Balato, Anna
    Enerback, Charlotta
    Sabat, Robert
    LANCET, 2021, 397 (10275): : 754 - 766
  • [2] Discovery of the IL-23/IL-17 Signaling Pathway and the Treatment of Psoriasis
    Hawkes, Jason E.
    Yan, Bernice Y.
    Chan, Tom C.
    Krueger, James G.
    JOURNAL OF IMMUNOLOGY, 2018, 201 (06): : 1605 - 1613
  • [3] Interleukin (IL)-19 is a novel component of the pathogenetic IL-23/IL-17 pathway in psoriasis
    Witte, E.
    Kokolakis, G.
    Witte, K.
    Philipp, S.
    Babel, N.
    Wittig, B. M.
    Erdmann-Keding, M.
    Kadin, M. E.
    Volk, H. -D.
    Sterry, W.
    Wolk, K.
    Sabat, R.
    BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 (06) : E155 - E155
  • [4] Targeting the IL-23/IL-17 Pathway in Psoriasis: the Search for the Good, the Bad and the Ugly
    Sofie Mylle
    Lynda Grine
    Reinhart Speeckaert
    Jo L.W. Lambert
    Nanja van Geel
    American Journal of Clinical Dermatology, 2018, 19 : 625 - 637
  • [5] Targeting the IL-23/IL-17 Pathway in Psoriasis: the Search for the Good, the Bad and the Ugly
    Mylle, Sofie
    Grine, Lynda
    Speeckaert, Reinhart
    Lambert, Jo L. W.
    van Geel, Nanja
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2018, 19 (05) : 625 - 637
  • [6] Expression of IL-23 and IL-17 and effect of IL-23 on IL-17 production in ankylosing spondylitis
    Wang, Xinwei
    Lin, Zhiming
    Wei, Qiujing
    Jiang, Yingjuan
    Gu, Jieruo
    RHEUMATOLOGY INTERNATIONAL, 2009, 29 (11) : 1343 - 1347
  • [7] Expression of IL-23 and IL-17 and effect of IL-23 on IL-17 production in ankylosing spondylitis
    Xinwei Wang
    Zhiming Lin
    Qiujing Wei
    Yingjuan Jiang
    Jieruo Gu
    Rheumatology International, 2009, 29 : 1343 - 1347
  • [8] The IL-23/IL-17 pathway in inflammatory bowel disease
    Geremia, Alessandra
    Jewell, Derek P.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2012, 6 (02) : 223 - 237
  • [9] Effects of the IL-23–IL-17 pathway on bone in spondyloarthritis
    Ellen M. Gravallese
    Georg Schett
    Nature Reviews Rheumatology, 2018, 14 : 631 - 640
  • [10] The Role of the IL-23/IL-17 Pathway in the Pathogenesis of Spondyloarthritis
    Tsukazaki, Hiroyuki
    Kaito, Takashi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (17) : 1 - 19